News & Updates
Filter by Specialty:

Seladelpar benefit in PBC sustained at 3 years
22 May 2025
byAudrey Abella
The selective PPARδ* agonist seladelpar continues to demonstrate benefit in patients with primary biliary cholangitis (PBC) in the long-term pooled analysis from the ongoing open-label phase III ASSURE trial.
Seladelpar benefit in PBC sustained at 3 years
22 May 2025
TrUST study heralds new era for TB diagnosis
21 May 2025
byAudrey Abella
A suite of deep learning (DL) models to automate tuberculosis (TB) risk assessment from lung ultrasound (LUS) images fulfils the WHO criteria for a sputum-free TB triage test and outwits human experts in the TrUST study.